Last updated
트리오어 (Triore): Capital Raising
Korean ADC drug developer Triore closed a 33 billion won Series C in a multi-closing round, bringing cumulative funding to 77 billion won. Participants include Korea Development Bank (120億원 from KDB), DS Asset Management (5 billion won via the National Growth Fund), HB Investment, Sage Partners, Tesla Investment Partners, and existing investors such as Woori Venture Partners, LSK Investment, Shinhan Capital and Snic Pick Investment.
Source: WOWTALE — Korea startup rounds
- What happened
- Korean ADC drug developer Triore closed a 33 billion won Series C in a multi-closing round, bringing cumulative funding to 77 billion won. Participants include Korea Development Bank (120億원 from KDB), DS Asset Management (5 billion won via the National Growth Fund), HB Investment, Sage Partners, Tesla Investment Partners, and existing investors such as Woori Venture Partners, LSK Investment, Shinhan Capital and Snic Pick Investment.
- Who
- 트리오어 (Triore) · South Korea
- When
- 2026-10-23
- So what
- 트리오어 (Triore)'s raise resets the leadership agenda more than the balance sheet.
The leadership read
트리오어 (Triore)'s raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Asia.
Market context: This lands while the Talent Market Index reads 122.7 (Hot) — up 17.8 versus the prior month — and Asia signal share is rising (+8.2pts).
트리오어 (Triore): 1 signal in the last 90 days.
MitchelLake in this thematic
More signals across Asia
Capital Raising · Asia
Even Health →Even Health raised a $50 Mn Series B led by Khosla Ventures with Alpha Wave participating, per the Inc42 weekly Indian startup funding roundup (19 Oct 2026).
Capital Raising · Asia
Different AI →Different AI closed a $48 Mn seed round led by General Catalyst with Lightspeed Venture Partners, per the Inc42 weekly funding roundup (22 Oct 2026).
Capital Raising · Asia
마이오렌지 →MyOrange, an impact-tech firm, was selected for Korea's TIPS R&D program, securing about 1.06 billion won (including 800 million won government funding) to build an AI platform automating social impact measurement and reporting.
Capital Raising · Asia
뉴럴웨이브 (Neuralwave) →Korean AI startup Neuralwave (뉴럴웨이브) says it raised KRW 300 million (3억 원) from the Credit Guarantee Fund (신용보증기금) through the Startup Nest program to fund marketing, and is preparing a customer-engagement and AEO/GEO marketing automation package.
Capital Raising · Asia
Sun Pharma →Sun Pharma raised ₹7,816 crore through five- and seven-year bonds priced at 8.05% and 8.20%, falling short of its ₹10,000 crore target; ₹2,100 crore came via anchor investors.
Capital Raising · Asia
SK Hyper →SK Hyper is seeking financing partners from technology companies and financial investors to fund a proposed $350 billion AI data center infrastructure buildout. No capital has been raised or committed yet.
Where this lands in our work
- Executive Search →
Capital raised becomes leadership hired — the executive build follows the announcement.
- Executive Search: Asia →
Our Asia practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
Nearby in the record